📰 Postoperative Nausea News
Postoperative Nausea News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Postoperative Nausea. Real-time updates on events, politics, business and more.
March 12, 2024
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results...
January 31, 2024
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The
October 9, 2023
A recent foray to Anchorage to visit neurosurgeryland for a back ailment left me reflecting on the need to feed and the need to read. One of my favorite songs
August 14, 2023
Company is well capitalized after signing $50 million working capital credit facility and recent $30 million equity raiseFavorable outcome at Markman hearing in pending CINVANTI® ANDA patent... -Today at 04:06 pm- MarketScreener
August 14, 2023
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company focused on improving the lives of...
June 28, 2023
Nausea and vomiting is a common problem that could be caused by conditions affecting the digestive tract or other systems of the body or due to infections.
March 6, 2023
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing...
May 3, 2022
Millikin's Celebrations of Scholarship highlights academic excellence
February 24, 2021
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates News provided by Share this article Share this article SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for...